JPRN-jRCT2080221160未知1 期
A Phase 1b, Open-Label Study to Evaluate the Safety of AMG 479 in Combination with Gemcitabine as First-line Therapy for Metastatic Pancreatic Cancer
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Major inclusion criteria include the following:
- •1)Subjects must have histologically or cytologically documented and confirmed metastatic adenocarcinoma of the pancreas
- •2)Eastern Cooperative Oncology Group (ECOG) score of 0 or 1
- •3)Men or women over 20 years old of age
排除标准
- •Major exclusion criteria include the following:
- •1)Islet cell, acinar cell carcinoma, non-adenocarcinoma, (eg, lymphoma, sarcoma, etc), adenocarcinoma originated from biliary tree or cystadenocarcinoma
- •2)Known history of central nervous system metastases
- •3)Internal or external biliary drain
- •4)A history of other malignancies
研究者
相似试验
进行中（未招募）
1 期
Hepatitis C Study with GT 1 2 and 3.Chronic Hepatitis C infectionMedDRA version: 20.0 Level: LLT Classification code 10076789 Term: Chronic hepatitis C genotype 2 System Organ Class: 100000004862MedDRA version: 20.0 Level: LLT Classification code 10076831 Term: Chronic hepatitis C genotype 3 System Organ Class: 100000004862MedDRA version: 20.0 Level: LLT Classification code 10076786 Term: Chronic hepatitis C genotype 1 System Organ Class: 100000004862EUCTR2016-002845-46-GBAlios BioPharma, Inc.161
进行中（未招募）
1 期
A study to understand the safety and effectiveness of an investigational drug called Selgantolimod in combination with other drugs for the treatment of long term hepatitis B infectioChronic Hepatitis B (CHB)MedDRA version: 20.1Level: PTClassification code 10008910Term: Chronic hepatitis BSystem Organ Class: 10021881 - Infections and infestationsEUCTR2021-000672-11-DKGilead Sciences, Inc.120
已完成
1 期
A Phase 1, Open-Label, Multiple Ascending Dose (MAD) Study of SM04646 Inhalation Solution in Subjects with Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF)ACTRN12617000854336Samumed Pacific Pty Ltd10
已完成
1 期
A Phase 1, Open-Label, Single Ascending Dose (SAD) Study of SM04646 Inhalation Solution in Healthy SubjectsACTRN12615001349538Samumed Pacific Pty Ltd17
招募中
1 期
A Phase 1b, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI5752 in Combination with Axitinib in Subjects with Advanced Renal Cell CarcinomaAdvanced Renal Cell CarcinomaMedDRA version: 20.0Level: SOCClassification code: 10029104Term: Neoplasms benign malignant and unspecified (incl cysts and polyps) Class: 2MedDRA version: 21.1Level: PTClassification code: 10067946Term: Renal cell carcinoma Class: 100000004864CTIS2023-509604-15-00AstraZeneca AB179